Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours Β· Estimated delivery Aug 31 - Sep 5
#AcuteDecompensation #ACLF #Inflammation #LiverDisease #GENFIT #G1090N *G1090N is an investigational drug candidate.* European Foundation for the Study of Chronic Liver Failure (EF CLIF), European Liver Patients' Association - ELPA Global Liver Institute American Liver Foundation To view or add a comment, sign in Following recent Phase 1 data that provided a solid foundation for advancing G1090N into Phase 2 proof-of-concept studies across the ACLF continuum, explore our latest scientific poster presented at AASLD 2025 to learn more about its active metabolite and earlier body of evidence
Theres minimal downtime
These ingredients are safe, but some people may experience: 1
Ancak nadir de olsa enjeksiyon blgesinde ar, ba ars, mide bulants veya alerjik reaksiyonlar grlebilir
US$ 22.13
US$ 20.00
US$ 21.50
